SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019908
Filing Date
2021-08-16
Accepted
2021-08-16 07:46:04
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1005686
2 ex31-1.htm EX-31.1 11727
3 ex31-2.htm EX-31.2 11716
4 ex32-1.htm EX-32.1 6935
5 ex32-2.htm EX-32.2 6927
  Complete submission text file 0001493152-21-019908.txt   4112617

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sonn-20210630.xsd EX-101.SCH 37490
7 XBRL CALCULATION FILE sonn-20210630_cal.xml EX-101.CAL 50531
8 XBRL DEFINITION FILE sonn-20210630_def.xml EX-101.DEF 136607
9 XBRL LABEL FILE sonn-20210630_lab.xml EX-101.LAB 279561
10 XBRL PRESENTATION FILE sonn-20210630_pre.xml EX-101.PRE 221280
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 510953
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 211174567
SIC: 2834 Pharmaceutical Preparations